This post is from a suggested group
The Engine of Personalized Medicine: Regulatory Compliance, Automation, and Data Linkage in the Global Biobanking Market
The Biobanking Market involves the collection, processing, storage, and distribution of biological materials (biospecimens) and associated data for research purposes, particularly in genomics, drug discovery, and personalized medicine. Market growth is fundamentally driven by the explosion of population genomics initiatives worldwide, the rapid expansion of research into cell and gene therapies, and the growing demand from pharmaceutical and biotechnology companies for high-quality, well-annotated samples (e.g., tissues, blood products, nucleic acids). Biobanks are the essential link between clinical data and molecular research, making them critical infrastructure for translational science. The market is segmented into equipment (e.g., automated liquid nitrogen freezers, robotics), consumables, and software (Laboratory Information Management Systems - LIMS). A key discussion point for the group is the high initial capital expenditure and ongoing operational costs required for maintaining sample integrity (e.g., ultra-low temperature…